Burning Sun Employee “Anna” Tests Positive For Multiple Drugs

A team of researchers at the cistron piece of writing Institute in metropolis, Delaware, has with success treated chemotherapy-resistant carcinoma cells with the CRISPR gene-editing technique. The study was printed Dec. 21, 2018, in Molecular medical aid Oncolytics. In addition to creating drug-resistant carcinoma cells treatable with therapy, the approach offers the potential to boost quality of life for cancer patients. 

“In the broader sense, such AN approach would ultimately result in a reduced level of therapy needed to provide a similar tumor-killing activity, resulting in AN improvement within the quality of lifetime of a cancer patient,” the authors wrote. Although carcinoma was the main target of the study, the approach may provide a replacement treatment avenue for carcinoma. Many of the medication presently in clinical trials for treating carcinoma were studied 1st as carcinoma therapies.

READ THE NEXT PAGE

1 2

Share this post